These involve genes like MUC16 (CA125) whose levels relate to different stages of NSCLC [61], and PTK7 that is associated with lymph node metastasis as well as ALK and EGFR mutations in lung cancer [62]. This evidence concerns the gene MUC16 and metastatic malignant neoplasm in the lymph nodes.